Pre-IVF Evaluation of the Infertile Man

  • Brooke Harnisch
  • Robert D. Oates


In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) have revolutionized the treatment of male factor infertility. However, it is still critically important to fully evaluate the male with a well-considered history, comprehensive physical examination, and appropriate hormonal and genetic assays in order to arrive at as precise a diagnosis as possible prior to the institution of therapy. This allows the couple to be fully informed about the options available to them, including ones that may result in an improvement in sperm parameters and fertility, result in subsequent natural conception, a move to intrauterine insemination from anticipated IVF, or an enhancement of IVF/ICSI success. Conditions or syndromes with general health implications are discovered with a complete work-up and the genetic basis of many can be elucidated. If the perspective is that the potential child that we are helping to create is part of the total equation, then any genetic maladies that might be transmitted to him/her should be determined and the couple educated about them with the options to possibly prevent that transmission discussed.


Seminal Vesicle Assisted Reproductive Technology Anabolic Steroid Primary Ciliary Dyskinesia Preimplantation Genetic Screening 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    AUA Best Practice Policy: Evaluation of the azoospermic male. Fertil Steril. Nov 2008;90(5 Suppl):S74-77.Google Scholar
  2. 2.
    Sigman M, Lipshultz L, Howards S. Office evaluation of the subfertile male. In: Lipshultz L, Howards S, Niederberger C, editors. Infertility in the male. 4th ed. New York: Cambridge University Press; 2009. p. 153–76.CrossRefGoogle Scholar
  3. 3.
    McLachlan RI, Krausz C. Clinical evaluation of the infertile male: new options, new challenges. Asian J Androl. 2012;14(1):3–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Mulholland J, Mallidis C, Agbaje I, McClure N. Male diabetes mellitus and assisted reproduction treatment outcome. Reprod Biomed Online. 2010;22(2):215–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Handyside AH. Preimplantation genetic diagnosis after 20 years. Reprod Biomed Online. 2010;21(3):280–2.PubMedCrossRefGoogle Scholar
  6. 6.
    Leigh MW, Pittman JE, Carson JL, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009;11(7):473–87.PubMedCrossRefGoogle Scholar
  7. 7.
    Canavese F, Mussa A, Manenti M, et al. Sperm count of young men surgically treated for cryptorchidism in the first and second year of life: fertility is better in children treated at a younger age. Eur J Pediatr Surg. 2009;19(6):388–91.PubMedCrossRefGoogle Scholar
  8. 8.
    Chung E, Brock GB. Cryptorchidism and its impact on male fertility: a state of art review of current literature. Can Urol Assoc J. 2011;5(3):210–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Kolon TF, Patel RP, Huff DS. Cryptorchidism: diagnosis, treatment, and long-term prognosis. Urol Clin North Am. 2004;31(3):469–80. viii-ix.PubMedCrossRefGoogle Scholar
  10. 10.
    Trsinar B, Muravec UR. Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism. World J Urol. 2009;27(4):513–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Hadziselimovic F, Hadziselimovic NO, Demougin P, Oakeley EJ. Testicular gene expression in cryptorchid boys at risk of azoospermia. Sex Dev. 2011;5(2):49–59.PubMedCrossRefGoogle Scholar
  12. 12.
    Agoulnik AI, Huang Z, Ferguson L. Spermatogenesis in cryptorchidism. Methods Mol Biol. 2012;825:127–47.PubMedCrossRefGoogle Scholar
  13. 13.
    Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. J Urol. 2009;181(2):452–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson MJ, Dunn JK, Lipshultz LI, Coburn M. Semen quality and endocrine parameters after acute testicular torsion. J Urol. 1992;147(6):1545–50.PubMedGoogle Scholar
  15. 15.
    Arap MA, Vicentini FC, Cocuzza M, et al. Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion. J Androl. 2007;28(4):528–32.PubMedCrossRefGoogle Scholar
  16. 16.
    Williamson RC. Torsion of the testis and allied conditions. Br J Surg. 1976;63(6):465–76.PubMedCrossRefGoogle Scholar
  17. 17.
    Domingo C, Mirapeix RM, Encabo B, Roig J, Lopez D, Ruiz J. Clinical features and ultrastructure of primary ciliary dyskinesia and Young syndrome. Rev Clin Esp. 1997;197(2):100–3.PubMedGoogle Scholar
  18. 18.
    Kim ED, Winkel E, Orejuela F, Lipshultz LI. Pathological epididymal obstruction unrelated to vasectomy: results with microsurgical reconstruction. J Urol. 1998;160(6 Pt 1):2078–80.PubMedGoogle Scholar
  19. 19.
    Sheynkin YR, Hendin BN, Schlegel PN, Goldstein M. Microsurgical repair of iatrogenic injury to the vas deferens. J Urol. 1998;159(1):139–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Kolettis PN, Thomas Jr AJ. Vasoepididymostomy for vasectomy reversal: a critical assessment in the era of intracytoplasmic sperm injection. J Urol. 1997;158(2):467–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Tanrikut C, Goldstein M. Obstructive azoospermia: a microsurgical success story. Semin Reprod Med. 2009;27(2):159–64.PubMedCrossRefGoogle Scholar
  22. 22.
    Grey BR, Thompson A, Jenkins BL, Payne SR. UK practice regarding reversal of vasectomy 2001–2010: relevance to best contemporary patient management. BJU Int. 2012. doi:10.1111/j.1464-410X.2011.10853.x.Google Scholar
  23. 23.
    Elzanaty S, Dohle GR. Vasovasostomy and predictors of vasal patency: a systematic review. Scand J Urol Nephrol. 2012;46:241–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Brannigan RE. Vasectomy reversal: indications and outcomes. J Urol. 2012;187(2):385–6.PubMedCrossRefGoogle Scholar
  25. 25.
    de Souza GL, Hallak J. Anabolic steroids and male infertility: a comprehensive review. BJU Int. 2011;108:1860–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Dohle GR, Smit M, Weber RF. Androgens and male fertility. World J Urol. 2003;21(5):341–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Lombardo F, Sgro P, Salacone P, et al. Androgens and fertility. J Endocrinol Invest. 2005;28(3 Suppl):51–5.PubMedGoogle Scholar
  28. 28.
    Ko EY, Siddiqi K, Brannigan RE, Sabanegh Jr ES. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol. 2012;187(3):973–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Damani MN, Master V, Meng MV, Burgess C, Turek P, Oates RD. Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol. 2002;20(4):930–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Chohan KR, Badawy SZ. Cigarette smoking impairs sperm bioenergetics. Int Braz J Urol. 2010;36(1):60–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Collodel G, Capitani S, Pammolli A, Giannerini V, Geminiani M, Moretti E. Semen quality of male idiopathic infertile smokers and nonsmokers: an ultrastructural study. J Androl. 2010;31(2):108–13.PubMedCrossRefGoogle Scholar
  32. 32.
    Gaur DS, Talekar MS, Pathak VP. Alcohol intake and cigarette smoking: impact of two major lifestyle factors on male fertility. Indian J Pathol Microbiol. 2010;53(1):35–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Huncharek M, Kupelnick B, Klassen H. Paternal smoking during pregnancy and the risk of childhood brain tumors: results of a meta-analysis. In Vivo. 2001;15(6):535–41.PubMedGoogle Scholar
  34. 34.
    Ji BT, Shu XO, Linet MS, et al. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst. 1997;89(3):238–44.PubMedCrossRefGoogle Scholar
  35. 35.
    Milne E, Greenop KR, Scott RJ, et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol. 2012;175(1):43–53.PubMedCrossRefGoogle Scholar
  36. 36.
    Santos EP, Lopez-Costa S, Chenlo P, et al. Impact of spontaneous smoking cessation on sperm quality: case report. Andrologia. 2011;43(6):431–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Braga DP, Halpern G, Figueira Rde C, Setti AS, Iaconelli Jr A, Borges Jr E. Food intake and social habits in male patients and its relationship to intracytoplasmic sperm injection outcomes. Fertil Steril. 2012;97(1):53–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int. 2012. doi:10.1111/j.1464-410X.2011.10813.x.Google Scholar
  39. 39.
    Relwani R, Berger D, Santoro N, et al. Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci. 2011;18(4):391–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Sermondade N, Massin N, Boitrelle F, et al. Sperm parameters and male fertility after bariatric surgery: three case series. Reprod Biomed Online. 2012;24(2):206–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Chipkevitch E, Nishimura RT, Tu DG, Galea-Rojas M. Clinical measurement of testicular volume in adolescents: comparison of the reliability of 5 methods. J Urol. 1996;156(6):2050–3.PubMedCrossRefGoogle Scholar
  42. 42.
    Peng J, Yuan Y, Zhang Z, et al. Patency rates of microsurgical vasoepididymostomy for patients with idiopathic obstructive azoospermia: a prospective analysis of factors associated with patency–single-center experience. Urology. 2012;79(1):119–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Nagler H, Grotas A. Varicocele. In: Lipshultz L, Howards S, Niederberger C, editors. Infertility in the male. 4th ed. New York: Cambridge University Press; 2009. p. 331–61.CrossRefGoogle Scholar
  44. 44.
    WHO. WHO laboratory manual for the examination and processing of human semen. 5th ed. Cambridge, England: Cambridge University Press; 2010.Google Scholar
  45. 45.
    Oates R. Evaluation of the azoospermic male. Asian J Androl. 2012;14(1):82–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Turner T. The epididymis and accessory sex organs. In: Lipshultz L, Howards S, Niederberger C, editors. Infertility in the male. 4th ed. New York: Cambridge University Press; 2009. p. 90–103.CrossRefGoogle Scholar
  47. 47.
    Oates RD. Clinical evaluation of the infertile male with respect to genetic etiologies. Syst Biol Reprod Med. 2011;57(1–2):72–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Smith JF, Walsh TJ, Turek PJ. Ejaculatory duct obstruction. Urol Clin North Am. 2008;35(2):221–7. viii.PubMedCrossRefGoogle Scholar
  49. 49.
    Hero M, Tommiska J, Vaaralahti K, et al. Circulating antimullerian hormone levels in boys decline during early puberty and correlate with inhibin B. Fertil Steril. 2012;97:1242–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Bonomi M, Libri DV, Guizzardi F, et al. New understandings of the genetic basis of isolated idiopathic central hypogonadism. Asian J Androl. 2012;14(1):49–56.PubMedCrossRefGoogle Scholar
  51. 51.
    Madani AH, Falahatkar S, Heidarzadeh A, Roshan ZA, Sazgari E, Zareian M. Sensitivity and specificity of serum FSH and testis size in predicting the existence of spermatogenesis in azoospermic infertile men. Andrologia. 2011;25:1–5.Google Scholar
  52. 52.
    Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97(3):707–18.PubMedCrossRefGoogle Scholar
  53. 53.
    Harnisch B, Oates R. Genetic disorders related to male factor infertility and their adverse consequences. Semin Reprod Med. 2012;30:105–15.PubMedCrossRefGoogle Scholar
  54. 54.
    Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2012;27(1):25–35.PubMedCrossRefGoogle Scholar
  55. 55.
    Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl. 2012;14(1):32–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Massart A, Lissens W, Tournaye H, Stouffs K. Genetic causes of spermatogenic failure. Asian J Androl. 2012;14(1):40–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Ramasamy R, Ricci JA, Palermo GD, Gosden LV, Rosenwaks Z, Schlegel PN. Successful fertility treatment for Klinefelter’s syndrome. J Urol. 2009;182(3):1108–13.PubMedCrossRefGoogle Scholar
  58. 58.
    Bakircioglu ME, Ulug U, Erden HF, et al. Klinefelter syndrome: does it confer a bad prognosis in treatment of nonobstructive azoospermia? Fertil Steril. 2011;95(5):1696–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art 2011. Hum Genet. 2012;131(2):175–86.PubMedCrossRefGoogle Scholar
  60. 60.
    Kuroda-Kawaguchi T, Skaletsky H, Brown LG, et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet. 2001;29(3):279–86.PubMedCrossRefGoogle Scholar
  61. 61.
    Navarro-Costa P, Plancha CE, Goncalves J. Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility? J Biomed Biotechnol. 2010;2010:936569.PubMedCrossRefGoogle Scholar
  62. 62.
    Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423(6942):825–37.PubMedCrossRefGoogle Scholar
  63. 63.
    Repping S, Skaletsky H, Lange J, et al. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet. 2002;71(4):906–22.PubMedCrossRefGoogle Scholar
  64. 64.
    Costa P, Goncalves R, Ferras C, et al. Identification of new breakpoints in AZFb and AZFc. Mol Hum Reprod. 2008;14(4):251–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Hopps CV, Mielnik A, Goldstein M, Palermo GD, Rosenwaks Z, Schlegel PN. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod. 2003;18(8):1660–5.PubMedCrossRefGoogle Scholar
  66. 66.
    Patrat C, Bienvenu T, Janny L, et al. Clinical data and parenthood of 63 infertile and Y-microdeleted men. Fertil Steril. 2010;93(3):822–32.PubMedCrossRefGoogle Scholar
  67. 67.
    Simoni M, Tuttelmann F, Gromoll J, Nieschlag E. Clinical consequences of microdeletions of the Y chromosome: the extended Munster experience. Reprod Biomed Online. 2008;16(2):289–303.PubMedCrossRefGoogle Scholar
  68. 68.
    Stahl PJ, Masson P, Mielnik A, Marean MB, Schlegel PN, Paduch DA. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertil Steril. 2010;94(5):1753–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Gambera L, Governini L, De Leo V, et al. Successful multiple pregnancy achieved after transfer of frozen embryos obtained via intracytoplasmic sperm injection with testicular sperm from an AZFc-deleted man. Fertil Steril. 2010;94(6):2330.e1–3.CrossRefGoogle Scholar
  70. 70.
    Mulhall JP, Reijo R, Alagappan R, et al. Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum Reprod. 1997;12(3):503–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Oates RD, Mulhall J, Burgess C, Cunningham D, Carson R. Fertilization and pregnancy using intentionally cryopreserved testicular tissue as the sperm source for intracytoplasmic sperm injection in 10 men with non-obstructive azoospermia. Hum Reprod. 1997;12(4):734–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Oates RD, Silber S, Brown LG, Page DC. Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI. Hum Reprod. 2002;17(11):2813–24.PubMedCrossRefGoogle Scholar
  73. 73.
    Samli H, Samli MM, Yilmaz E, Imirzalioglu N. Clinical, andrological and genetic characteristics of patients with congenital bilateral absence of vas deferens (CBAVD). Arch Androl. 2006;52(6):471–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A. Role of genetics in azoospermia. Urology. 2010;77(3):598–601.PubMedCrossRefGoogle Scholar
  75. 75.
    Bareil C, Guittard C, Altieri JP, Templin C, Claustres M, des Georges M. Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders. J Mol Diagn. 2007;9(5):582–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Grzegorczyk V, Rives N, Sibert L, Dominique S, Mace B. Management of male infertility due to congenital bilateral absence of vas deferens should not ignore the diagnosis of cystic fibrosis. Andrologia. 2012. doi:10.1111/j.1439-0272.2012.01288.x.Google Scholar
  77. 77.
    McCallum T, Milunsky J, Munarriz R, Carson R, Sadeghi-Nejad H, Oates R. Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum Reprod. 2001;16(2):282–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Miyaoka R, Esteves SC. A critical appraisal on the role of varicocele in male infertility. Adv Urol. 2012;2012:597495.PubMedGoogle Scholar
  79. 79.
    Schlegel PN, Goldstein M. Alternate indications for varicocele repair: non-obstructive azoospermia, pain, androgen deficiency and progressive testicular dysfunction. Fertil Steril. 2011;96(6):1288–93.PubMedCrossRefGoogle Scholar
  80. 80.
    Abdel-Meguid TA. Predictors of sperm recovery and azoospermia relapse in men with nonobstructive azoospermia after varicocele repair. J Urol. 2012;187(1):222–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Fenig DM, Kattan MW, Mills JN, Gisbert M, Yu C, Lipshultz LI. Nomogram to preoperatively predict the probability of requiring epididymovasostomy during vasectomy reversal. J Urol. 2012;187(1):215–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Hsiao W, Goldstein M, Rosoff JS, et al. Nomograms to predict patency after microsurgical vasectomy reversal. J Urol. 2012;187(2):607–12.PubMedCrossRefGoogle Scholar
  83. 83.
    van Dongen J, Tekle FB, van Roijen JH. Pregnancy rate after vasectomy reversal in a contemporary series: influence of smoking, semen quality and post-surgical use of assisted reproductive techniques. BJU Int. 2012;110:562–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Esteves SC, Miyaoka R, Agarwal A. Sperm retrieval techniques for assisted reproduction. Int Braz J Urol. 2011;37(5):570–83.PubMedGoogle Scholar
  85. 85.
    Oates RD, Lobel SM, Harris DH, Pang S, Burgess CM, Carson RS. Efficacy of intracytoplasmic sperm injection using intentionally cryopreserved epididymal spermatozoa. Hum Reprod. 1996;11(1):133–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Schroeder-Printzen I, Zumbe J, Bispink L, et al. Microsurgical epididymal sperm aspiration: aspirate analysis and straws available after cryopreservation in patients with non-reconstructable obstructive azoospermia. MESA/TESE Group Giessen. Hum Reprod. 2000;15(12):2531–5.PubMedCrossRefGoogle Scholar
  87. 87.
    Van Peperstraten A, Proctor ML, Johnson NP, Philipson G. Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia. Cochrane Database Syst Rev. 2008;(2):CD002807Google Scholar
  88. 88.
    Schlegel PN. Nonobstructive azoospermia: a revolutionary surgical approach and results. Semin Reprod Med. 2009;27(2):165–70.PubMedCrossRefGoogle Scholar
  89. 89.
    Yarali H, Polat M, Bozdag G, et al. TESE-ICSI in patients with non-mosaic Klinefelter syndrome: a comparative study. Reprod Biomed Online. 2009;18(6):756–60.PubMedCrossRefGoogle Scholar
  90. 90.
    Fullerton G, Hamilton M, Maheshwari A. Should non-mosaic Klinefelter syndrome men be labelled as infertile in 2009? Hum Reprod. 2010;25(3):588–97.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of UrologyBoston Medical CenterBostonUSA
  2. 2.Department of UrologyBoston University School of MedicineBostonUSA

Personalised recommendations